Human Papilloma Virüs (Hpv) Enfeksiyonu Olan Bireyde Hemşirelik Bakımı: Olgu Sunumu

Abstract

Human Papilloma Virüs (HPV) enfeksiyonu alt genital sistemin cinsel yolla bulaşan hastalıkları içerisinde en yaygın olanıdır. HPV ciltteki lezyonlardan, kontamine yüzeylerden ve doğum kanalından, direkt veya indirekt olmak üzere birçok şekilde bulaşabilmekte; fakat en önemli bulaş yolunun cinsel yol olduğu bildirilmektedir. Prevalansı oldukça yüksek olan HPV enfeksiyonunun dünya genelinde birçok bireyi ciddi oranda etkilediği ve servikal kanser riski oluşturduğu belirtilmektedir. Tedavi ve bakımın yanında HPV enfeksiyonunu önleme çalışmaları büyük öneme sahiptir. Hemşirenin koruyucu sağlık hizmetlerindeki rolü, tedaviyi uygulayıcı rolü, bakım verici rolüne ek olarak eğitimci rolü de virüsün yayılımının önlenmesinde önem arz etmektedir. Daha önce HPV enfeksiyonu hakkında bilgisi olmayan ve pap smear testi yaptırmamış olan bu olgu sunumunda; Human Papilloma Virüs (tip 16) enfeksiyonu olan bireyde hemşirelik bakımının NANDA- I sınıflama sistemi doğrultusunda sunulması amaçlanmıştır.

Keywords

• HPV
• hemşirelik
• hemşirelik bakımı
• NANDA-I.

Nursing Care in A Person With Human Papilloma Virus (Hpv) Infection: A Case Report

Abstract

Human Papilloma Virus (HPV) infection is the most common sexually transmitted disease of the lower genital tract. HPV can be transmitted from skin lesions, contaminated surfaces and birth canal in many ways, either directly or indirectly; However, it is reported that the most important transmission route is sexual. It is stated that HPV infection, which has a very high prevalence, affects many individuals worldwide and poses a risk of cervical cancer. In addition to treatment and care, efforts to prevent HPV infection are of great importance. The role of the nurse in preventive health services, the role of implementing the treatment and the role of the educator, in addition to the role of caregiver, are also important in preventing the spread of the virus. In the case who had no previous knowledge about HPV infection and did not have a pap smear test; It is aimed to present nursing care in individuals with Human Papilloma Virus (type 16) infection in line with the NANDA - I classification system.

Keywords

• HPV
• nursing
• nursing care
• NANDA-I

References

1. Wıllıamson, Anna-Lise. Recent developments in human papillomavirus (HPV) Vaccinology. Viruses, 2023;15.7: 1440.
2. Lin C, Franceschi S, Clifford G.M. Human papillomavirus types from infection to cancer in the anus, according to sex and HIV status: A systematic review and meta-analysis. Lancet Infect. Dis. 2018; 18, 198–206.
3. World Health Organization World Health Organization [Internet]. Human papilloma virus (HPV) and cervical cancer. 2020 [updated 2022 Nov 23; cited]. Available from: https://www.who.int/news-room/fact-sheets/detail/cervical-cancer
4. O’Mahony C, Gomberg M, Skerlev M, Alraddadi A, de las Heras‐Alonso ME, et al. Position statement fot the diagnosis and management of anogenital warts. J Eur Acad Dermatol Venereol, 2019; 33(6): 1006-1019. https://doi.org/10.1111/jdv.15570
5. Skoulakis A, Fountas S, Mantzana-Peteinelli, M. Pantelidi K. Petinaki E. Prevalence of human papilloma virus and subtype distribution in malepartners of women with cervical intraepithelial neoplasia (CIN): A systematic review. BMC Infect Dis. 2019; 19(1):2–11.
6. Bruni L, Albero G, Serrano B, Mena M, Gómez D, et al. ICO/IARC Information Centre on HPV and Cancer (HPV Information Centre). Human papilloma virus and related diseases in Turkey. 2021; Summary report 22 October 2021.
7. Böyük M, Çıtak Bilgin N. HPV enfeksiyonuna güncel bir bakış: nedenleri, etkileri ve korunma. Abant Sağlık Bilimleri ve Teknolojileri Dergisi. 2023; 3(1): 40-47.
8. Stoler MH. Human papilloma viruses and cervical neoplasia: a model for carcinogenesis, Int J Gynecol Pathol. 2000; 19, 16-28.

9. Syrjänen S. Oral manifestations of human papillomavirus ınfections. Eur. J. Oral Sci. 2018; 126, 49–66.
10. Morgan RL, Thayer KA, Santesso N, Holloway AC, Blain R, Eftim SE, et al. Evaluation of the risk of bias in non-randomized studies of ınterventions and the ‘target experiment’ concept in studies of exposures: rationale and preliminary ınstrument development. Environ. Int. 2018; 120, 382–387.
11. Sterne JA, Hernán MA, Reeves BC, Savović J, Berkman ND, Viswanathan M, et al. Robıns-I: A tool for assessing risk of bias in non-randomised studies of ınterventions. BMJ 2016; 355, 491.
12. Petca A, Borislavschi A, Zvanca M, Petca RC, Sandru F, Dumitrascu M. Non-Sexual HPV transmission and role of vaccination for a better future (Review). Exp. Ther. Med. 2020; 20, 1.
13. Di Spirito F, Pantaleo G, Di Palo MP, Amato A, Raimondo A, Amato M. Oral human papillomavirus benign lesions and hpv-related cancer in healthy children: a systematic review. Cancers. 2023; 15(4):1096. https://doi.org/10.3390/cancers15041096 Santella B, Schettino MT, Franci G, De Franciscis P, Colacurci N, Schiattarella A, et al. Microbiota and HPV: The role of viral infection on vaginal microbiota. J. Med. Virol. 2022; 94, 4478–4484.
14. Yoshpe NS. Oral and laryngeal papilloma: a pediatric manifestation of sexually transmitted disease? Int. J. Pediatr. Otorhinolaryngol. 1995; 31, 77–83.
15. Bennett LK, Hinshaw M. Heck’s disease: diagnosis and susceptibility. Pediatr. Dermatol. 2009; 26, 87–89.
16. Binder B, Wieland U, Smolle J. Focal epithelial hyperplasia (heck disease) in a black child. Pediatr. Dermatol. 2007; 24, 31–32.
17. Bombeccari GP, Pallotti F, Guzzi G, Spadari F. Diode laser therapy for heck’s disease associated with HPV ınfection. J. Eur. Acad. Dermatol. Venereol. 2009; 23, 197–198.
18. Borborema-Santos CM, de Castro MM, dos Santos PJB, Talhari S, Astolfi-Filho S. Oral focal epithelial hyperplasia: report of five cases. Braz. Dent. J. 2006; 17, 79–82.
19. Thaker Juthika, Albers Alexandria N, Newcomer Sophia R. Nurses’ perceptions, experiences, and practices regarding human papillomavirus vaccination: results from a cross-sectional survey in Montana. BMC Nursing, 2023; 22.1: 211.
20. Coombs NC, Campbell DG, Caringi J. A qualitative study of rural healthcare providers’ views of social, cultural, and programmatic barriers to healthcare access. BMC Health Serv Res. 2022;22(1):438. https://doi.org/10.1186/s12913-022-07829-2.
21. Peterson CE, Silva A, Holt HK, Balanean A, Goben AH, Dykens JA. Barriers and facilitators to HPV vaccine uptake among US rural populations: a scoping review. Cancer Causes Control. 2020;31(9):801–14.
22. Centers for Disease Control and Prevention. HPV infection. Centers for Disease Control and Prevention. 2021, July 23. Retrieved from https://www.cdc.gov/hpv/parents/about-hpv.html.
23. Boyce TG, Christianson B, Hanson KE et al. Factors associated with human papillomavirus and meningococcal vaccination among adolescents living in rural and urban areas. 2022;11:100180. Tanrısu Över M. Türkiye sağlık okuryazarlığı araştırması. http: // www. sagliksen. org.tr/ MediaConte nt/vYcK-1419245270-mA r.
24. Zahnd, Whitney E.; Rodrıguez, Christofer; Jenkıns, Wiley D. Rural‐Urban Differences in Human Papillomavirus‐associated Cancer Trends and Rates. The Journal of Rural Health, 2019; 35(2): 208-215.
25. Yılmaz B, Hat BN, Yürekli Y, Oskay Ü. Genç erişkinlerin human papilloma virüs (hpv) ve hpv aşısına ilişkin bilgi ve görüşleri: Kesitsel bir çalışma. KOU Sag Bil Derg. 2021; 7(2): 138-148.
26. Human papilloma virüs https://www.centro.com.tr/wp-content/uploads/2018/12/HPV.pdf Mercan R, Mercan S, Durmaz B, Sur H, Kilciksiz CM, Kacar AS, et al. Sexual dysfunction in women with human papilloma virus infection in the Turkish population. Journal of Obstetrics and Gynaecology, 2019; 39(5), 659–663.
27. Anic GM, Giuliano AR. Genital HPV infection and related lesions in men. Prev Med. 2011; 53(1):36–41.
28. Escalas J, Rodriguez-Cerdeir C & Guerra-Tapia A. Impact of HPV infection on the quality of life in young women. The Open Dermatology Journal, 2009; 3(1), 137– 139.
29. Nack, A. Damaged goods?: Women living with ıncurable sexually transmitted diseases (1st ed.). 2008; Temple University Press.